ERBB2 and cancer: Interestingly, SORLA silencing also attenuated the recycling of β1-integrins (without influencing endocytosis; Supplementary Fig. 4b, c), suggesting that in cancer cells SORLA could be linked to trafficking of other receptors in addition to HER2.